{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,17]],"date-time":"2026-08-17T14:06:51Z","timestamp":1786975611882,"version":"build-2736575974"},"reference-count":15,"publisher":"American Medical Association (AMA)","issue":"6","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["JAMA Dermatol"],"published-print":{"date-parts":[[2020,6,1]]},"DOI":"10.1001\/jamadermatol.2020.0464","type":"journal-article","created":{"date-parts":[[2020,4,22]],"date-time":"2020-04-22T11:32:18Z","timestamp":1587555138000},"page":"619","source":"Crossref","is-referenced-by-count":21,"title":["A New Class of Topical Acne Treatment Addressing the Hormonal Pathogenesis of Acne"],"prefix":"10.1001","volume":"156","author":[{"given":"John S.","family":"Barbieri","sequence":"first","affiliation":[{"name":"Department of Dermatology, Perelman School of Medicine, University of Pennsylvania, Philadelphia"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"10","reference":[{"issue":"3","key":"ded200004r1","doi-asserted-by":"crossref","first-page":"474","DOI":"10.1111\/bjd.12149","article-title":"Epidemiology of acne vulgaris.","volume":"168","author":"Bhate","year":"2013","journal-title":"Br J Dermatol"},{"issue":"1","key":"ded200004r2","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1016\/j.jaad.2007.06.045","article-title":"The prevalence of acne in adults 20 years and older.","volume":"58","author":"Collier","year":"2008","journal-title":"J Am Acad Dermatol"},{"issue":"5","key":"ded200004r3","doi-asserted-by":"crossref","first-page":"406","DOI":"10.1001\/jamadermatol.2016.5538","article-title":"Global skin disease morbidity and mortality: an update from the Global Burden of Disease Study 2013.","volume":"153","author":"Karimkhani","year":"2017","journal-title":"JAMA Dermatol"},{"issue":"2","key":"ded200004r5","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1007\/s40257-016-0245-x","article-title":"Oral spironolactone for acne vulgaris in adult females: a hybrid systematic review.","volume":"18","author":"Layton","year":"2017","journal-title":"Am J Clin Dermatol"},{"issue":"1","key":"ded200004r6","doi-asserted-by":"crossref","first-page":"110","DOI":"10.1038\/jid.2014.290","article-title":"Propionibacterium acnes promotes Th17 and Th17\/Th1 responses in acne patients.","volume":"135","author":"Kistowska","year":"2015","journal-title":"J Invest Dermatol"},{"issue":"5","key":"ded200004r7","doi-asserted-by":"crossref","first-page":"945","DOI":"10.1016\/j.jaad.2015.12.037","article-title":"Guidelines of care for the management of acne vulgaris.","volume":"74","author":"Zaenglein","year":"2016","journal-title":"J Am Acad Dermatol"},{"issue":"2","key":"ded200004r8","doi-asserted-by":"crossref","first-page":"538","DOI":"10.1016\/j.jaad.2018.09.055","article-title":"Approaches to limit systemic antibiotic use in acne: systemic alternatives, emerging topical therapies, dietary modification, and laser and light-based treatments.","volume":"80","author":"Barbieri","year":"2019","journal-title":"J Am Acad Dermatol"},{"key":"ded200004r9","article-title":"Efficacy and safety of topical clascoterone cream, 1%, for treatment in patients with facial acne.","author":"Hebert","journal-title":"JAMA Dermatol"},{"issue":"6","key":"ded200004r10","first-page":"563","article-title":"Pharmacokinetic profile, safety, and tolerability of clascoterone (cortexolone 17-alpha propionate, CB-03-01) topical cream, 1% in subjects with acne vulgaris: an open-label phase 2a study.","volume":"18","author":"Mazzetti","year":"2019","journal-title":"J Drugs Dermatol"},{"issue":"7","key":"ded200004r11","doi-asserted-by":"crossref","DOI":"10.1136\/bmjopen-2015-008085","article-title":"Identifying acne treatment uncertainties via a James Lind Alliance Priority Setting Partnership.","volume":"5","author":"Layton","year":"2015","journal-title":"BMJ Open"},{"issue":"1","key":"ded200004r12","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1111\/j.1365-2133.2011.10332.x","article-title":"Cortexolone 17a-propionate 1% cream, a new potent antiandrogen for topical treatment of acne vulgaris: a pilot randomized, double-blind comparative study vs. placebo and tretinoin 0\u00b705% cream.","volume":"165","author":"Trifu","year":"2011","journal-title":"Br J Dermatol"},{"issue":"6","key":"ded200004r13","first-page":"632","article-title":"Frequency of treatment switching for spironolactone compared to oral tetracycline-class antibiotics for women with acne: a retrospective cohort study 2010-2016.","volume":"17","author":"Barbieri","year":"2018","journal-title":"J Drugs Dermatol"},{"issue":"3","key":"ded200004r14","doi-asserted-by":"crossref","first-page":"456","DOI":"10.1016\/j.jaad.2017.04.016","article-title":"Trends in prescribing behavior of systemic agents used in the treatment of acne among dermatologists and nondermatologists: a retrospective analysis, 2004-2013.","volume":"77","author":"Barbieri","year":"2017","journal-title":"J Am Acad Dermatol"},{"issue":"2","key":"ded200004r15","doi-asserted-by":"crossref","first-page":"526","DOI":"10.1016\/j.jaad.2019.01.092","article-title":"Acne vulgaris: what\u2019s new in our 40th year.","volume":"82","author":"Harper","year":"2020","journal-title":"J Am Acad Dermatol"},{"key":"ded200004r4","unstructured":"American Academy of Dermatology. Burden of skin disease. 2017. Accessed February 5, 2020. https:\/\/www.aad.org\/member\/clinical-quality\/clinical-care\/bsd."}],"container-title":["JAMA Dermatology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/jamanetwork.com\/journals\/jamadermatology\/articlepdf\/2765022\/jamadermatology_barbieri_2020_ed_200004.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,6,10]],"date-time":"2020-06-10T13:45:26Z","timestamp":1591796726000},"score":1,"resource":{"primary":{"URL":"https:\/\/jamanetwork.com\/journals\/jamadermatology\/fullarticle\/2765022"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,6,1]]},"references-count":15,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2020,6,1]]}},"URL":"https:\/\/doi.org\/10.1001\/jamadermatol.2020.0464","relation":{},"ISSN":["2168-6068"],"issn-type":[{"value":"2168-6068","type":"print"}],"subject":[],"published":{"date-parts":[[2020,6,1]]}}}